Nicolini, F A <br/><br/>
Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.  [electronic resource] 

 -  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis  Jan 1996 
 - 39-48 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0957-5235 
<br/><br/><label>Standard No.: </label>10.1097/00001721-199601000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antithrombins--therapeutic use<br/>Arthropod Proteins<br/>Blood Coagulation Tests<br/>Coronary Thrombosis--drug therapy<br/>Disease Models, Animal<br/>Dogs<br/>Factor Xa Inhibitors<br/>Female<br/>Hirudin Therapy<br/>Intercellular Signaling Peptides and Proteins<br/>Male<br/>Microscopy, Electron, Scanning<br/>Peptides--therapeutic use<br/>Serine Proteinase Inhibitors--therapeutic use<br/>Sodium Chloride--pharmacology<br/>Thrombolytic Therapy<br/>Ticks<br/>Vascular Patency--drug effects